Current
Neuro-Oncology


Volume 20 Number 8
31 August 2018


Home > Publications > Current Neuro-Oncology > Volume 20, Year 2018 > Number 8, 31 August






Kang Z, Yang S, Zhang H, Zhou Q, Chen J, Li Y, Kang X, Li S, Li W.
Extracranial metastasis of anaplastic oligoastrocytoma.
Cancer Biol Med. 2018 Aug 1, 2018;15(3):311-313. doi: 10.20892/j.issn.2095-3941.2017.0181. PMID: 30197798. Case report. ˍ




Lee JH, Lee JE, Kahng JY, Kim SH, Park JS, Yoon SJ, Um JY, Kim WK, Lee JK, Park J, Kim EH, Lee JH, Lee JH, Chung WS, Ju YS, Park SH, Chang JH, Kang SG, Lee JH.
Human glioblastoma arises from subventricular zone cells with low-level driver mutations.
Nature. 2018 Aug 1. 2018;560(7717):243-247. doi: 10.1038/s41586-018-0389-3. PMID: 30069053. Laboratory investigation. ˍ




Lukas RV, Rodon J, Becker K, Wong ET, Shih K, Touat M, Fassò M, Osborne S, Molinero L, O'Hear C, Grossman W, Baehring J.
Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma.
J Neurooncol. 2018 Aug 2, 2018;140(2):317-328. doi: 10.1007/s11060-018-2955-9. PMID: 30073642. Interventional study. ˍ




Lee C, Robinson M, Willerth SM.
Direct Reprogramming of Glioblastoma Cells into Neurons Using Small Molecules.
ACS Chem Neurosci. 2018 Aug 9, 2018;9(12):3175-3185. doi: 10.1021/acschemneuro.8b00365. PMID: 30091580. Laboratory investigation. ˍ




Witzel I, Laakmann E, Weide R, Neunhöffer T, Park-Simon TJ, Schmidt M, Fasching PA, Hesse T, Polasik A, Mohrmann S, Würschmidt F, Schem C, Bechtner C, Würstlein R, Fehm T, Möbus V, Burchardi N, Loibl S, Müller V.
Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry.
Eur J Cancer. 2018 Aug 9,
2018;102:1-9. doi: 10.1016/j.ejca.2018.07.004. PMID: 30099223. Observational study. ˍ




Kondyli M, Larouche V, Saint-Martin C, Ellezam B, Pouliot L, Sinnett D, Legault G, Crevier L, Weil A, Farmer JP, Jabado N, Perreault S.
Trametinib for progressive pediatric low-grade gliomas.
J Neurooncol. 2018 Aug 10, 2018;140(2):435-444. doi: 10.1007/s11060-018-2971-9. PMID: 30097824. Observational study. ˍ




AlHarbi M, Ali Mobark N, AlMubarak L, Aljelaify R, AlSaeed M, Almutairi A, Alqubaishi F, Hussain ME, Balbaid AAO, Said Marie A, AlSubaie L, AlShieban S, alTassan N, Ramkissoon SH, Abedalthagafi M.
Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.
Oncologist. 2018 Aug 13, 2018;23(12):1401-1406. doi: 10.1634/theoncologist.2018-0163. PMID: 30104292. Case report. ˍ




Chongsathidkiet P, Jackson C, Koyama S, Loebel F, Cui X, Farber SH, Woroniecka K, Elsamadicy AA, Dechant CA, Kemeny HR, Sanchez-Perez L, Cheema TA, Souders NC, Herndon JE, Coumans JV, Everitt JI, Nahed BV, Sampson JH, Gunn MD, Martuza RL, Dranoff G, Curry WT, Fecci PE.
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors.
Nat Med. 2018 Aug 13, 2018;24(9):1459-1468. doi: 10.1038/s41591-018-0135-2. PMID: 30104766. Laboratory investigation. ˍ



*

van den Bent MJ, Klein M, Smits M, Reijneveld JC, French PJ, Clement P, de Vos FYF, Wick A, Mulholland PJ, Taphoorn MJB, Lewis J, Weller M, Chinot OL, Kros JM, de Heer I, Verschuere T, Coens C, Golfinopoulos V, Gorlia T, Idbaih A.
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial.
Lancet Oncol. 2018 Aug 13,
2018;19(9):1170-1179. doi: 10.1016/S1470-2045(18)30362-0. PMID: 30115593. Interventional study. ˍ




Hao J, Godley A, Shoemake JD, Han Z, Magnelli A, Yu JS.
The effects of extra high dose rate irradiation on glioma stem-like cells.
PLoS One. 2018 Aug 17, 2018;13(8):e0202533
. doi: 10.1371/journal.pone.0202533. PMID: 30118510. Laboratory investigation. ˍ




Patel NV, Schneider JR, Kwan K, Boockvar JA.
The Glioblastoma Cell Ecosystem: Signals Between Progenitors and Progeny.
Neurosurgery. 2018 Aug 17, 2018;83(3):E95
. doi: 10.1093/neuros/nyy296. PMID: 30125029. Comment. ˍ
Refers to: Wang X et al, Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression. Cell Stem Cell. 2018 Apr 5, 2018;22(4):514-528.e5. doi: 10.1016/j.stem.2018.03.011. PMID: 29625067. Laboratory investigation. ˍ




Press RH, Zhang C, Cassidy RJ, Ferris MJ, Zhong J, Steuer CE, Pillai RN, Owonikoko TK, Kahn S, Ramalingam SS, Patel PR, Curran WJ, Shu HG, Sica GL, Higgins KA.
Targeted Sequencing and Intracranial Outcomes of Patients With Lung Adenocarcinoma Brain Metastases Treated With Radiotherapy.
Cancer. 2018 Aug 18
, 2018;124(17):3586-3595. doi: 10.1002/cncr.31589. PMID: 30120912. Observational study. ˍ




Guzauskas GF, Salzberg M, Wang BC.
Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients.
CNS Oncol. 2018 Aug 20,
2018;7(3):CNS23. doi: 10.2217/cns-2018-0010. PMID: 30124334. Observational study. ˍ




Maxwell R, Luksik AS, Garzon-Muvdi T, Yang W, Huang J, Bettegowda C, Jallo GI, Terezakis SA, Groves M.
Population-based Study Determining Predictors of Cancer-Specific Mortality and Survival in Pediatric High-grade Brainstem Glioma.
World Neurosurg. 2018 Aug 20,
2018;119:e1006-e1015. doi: 10.1016/j.wneu.2018.08.044. PMID: 30138731. Observational study. ˍ




Blakeley JO, Grossman SA, Chi AS, Mikkelsen T, Rosenfeld MR, Ahluwalia MS, Nabors LB, Eichler A, Garcia-Ribas I, Desideri S, Ye X.
Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma.
Clin Cancer Res. 2018 Aug 21,
2019;25(1):73-79. doi: 10.1158/1078-0432.CCR-18-0110. PMID: 30131387. Interventional study. ˍ




Rice SR, Bentzen SM, Hanna A, Choi E, Boggs DH, Kwok Y, Hyder J, Feigenberg SJ, Regine WF, Woodworth GF, Eisenberg HM, Yu C, Biggins TF, Barnholtz-Sloan JS, Sperduto PW, Weltman E, Mehta MP.
Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study.
J Neurooncol. 2018 Aug 21,
2018;140(2):341-349. doi: 10.1007/s11060-018-2958-6. PMID: 30132164. Observational study. ˍ




Taylor JW, Parikh M, Phillips JJ, James CD, Molinaro AM, Butowski NA, Clarke JL, Oberheim-Bush NA, Chang SM, Berger MS, Prados M.
Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma.
J Neurooncol. 2018 Aug 27,
2018;140(2):477-483. doi: 10.1007/s11060-018-2977-3. PMID: 30151703. Interventional study. ˍ




Bota DA, Chung J, Dandekar M, Carrillo JA, Kong XT, Fu BD, Hsu FP, Schönthal AH, Hofman FM, Chen TC, Zidovetzki R, Pretto C, Strik A, Schijns VE, Stathopoulos A.
Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts.
CNS Oncol. 2018 Aug 29,
2018;7(3):CNS22. doi: 10.2217/cns-2018-0009. PMID: 30157683. Interventional study. ˍ




Wood H.
Addition of bevacizumab fails to improve on temozolomide alone for glioma therapy.
Nat Rev Neurol. 2018 Aug 29,
2018;14(10):570. doi: 10.1038/s41582-018-0067-y. PMID: 30158560. Comment. ˍ
Refers to: Van den Bent MJ et al.,Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial. Lancet Oncol. 2018 Aug 13, 2018;19(9):1170-1179. doi: 10.1016/S1470-2045(18)30362-0. PMID: 30115593. Interventional study. ˍ




Dotson J, Nijim A, Denning KL, Shweihat Y, Lebowicz Y.
A Rare Case of Metastases from a High-grade Astrocytoma to the Pleura, Bones, and Liver within Six Months of Diagnosis.
Cureus. 2018 Aug 30, 2018;10(8):e3234. doi: 10.7759/cureus.3234. PMID: 30410840. Case report. ˍ




Das M.
Iniparib improves survival in newly diagnosed glioblastoma.
Lancet Oncol. 2018 Aug 31,
2018;19(10):e514. doi: 10.1016/S1470-2045(18)30665-X. PMID: 30177496. Comment. ˍ
Refers to: Blakeley JO et al., Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma. Clin Cancer Res. 2018 Aug 21, 2019;25(1):73-79. doi: 10.1158/1078-0432.CCR-18-0110. PMID: 30131387. Interventional study. ˍ